Genmab — Juli 2019
-
Der skal da heller ikke være nogen jubel - Genmab betaler for at få adgang til et bioteksselskabs antistoffer mod CD47 - der går måske 3 år eller mere før vi ser noget i klinikken og til den tid kan det måske begynde at give noget på kursen (og kun lidt)
-
Ældre præsentation af dara og CD47 https://ir.genmab.com/static-files/fca2523b-a8fb-47f6-86ec-d02688804b28
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind